tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Compass Therapeutics management to meet virtually with Piper Sandler
PremiumThe FlyCompass Therapeutics management to meet virtually with Piper Sandler
2M ago
Compass Therapeutics: Positive Drug Data and Strategic Expansion Justify Buy Rating
Premium
Ratings
Compass Therapeutics: Positive Drug Data and Strategic Expansion Justify Buy Rating
3M ago
Compass Therapeutics price target lowered to $10 from $12 at Guggenheim
Premium
The Fly
Compass Therapeutics price target lowered to $10 from $12 at Guggenheim
3M ago
Compass Therapeutics’ Tovecimig Shows Promise in BTC Treatment, Supporting Buy Rating
PremiumRatingsCompass Therapeutics’ Tovecimig Shows Promise in BTC Treatment, Supporting Buy Rating
4M ago
Compass Therapeutics announces first patient dosed in IST evaluating tovecimig
Premium
The Fly
Compass Therapeutics announces first patient dosed in IST evaluating tovecimig
4M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
Compass Therapeutics price target raised to $11 from $10 at Stifel
PremiumThe FlyCompass Therapeutics price target raised to $11 from $10 at Stifel
4M ago
Compass Therapeutics Reports Positive Phase 2/3 Trial Results
Premium
Company Announcements
Compass Therapeutics Reports Positive Phase 2/3 Trial Results
4M ago
Compass Therapeutics says tovecimig meets primary endpoint in Phase 2/3 study
Premium
The Fly
Compass Therapeutics says tovecimig meets primary endpoint in Phase 2/3 study
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100